NEW YORK and MELBOURNE, Australia, June 18, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback